BOCA RATON, Fla.--(BUSINESS WIRE)--
TherapeuticsMD?, Inc. [OTCQB: TXMD], parent company of vitaMedMD®,
LLC ("vitaMedMD"), a specialty pharmaceutical company ("TherapeuticsMD"
or the "Company"), announced that on May 16, 2012 the Company's Board of
Directors elected Tommy G. Thompson, former U.S. Secretary of Health and
Human Services, as Chairman of its Board of Directors. Robert G.
Finizio, former Chairman of the Board, will continue to serve in his
capacity as director and Chief Executive Officer of the Company.
Robert Finizio, the Company's Chief Executive Officer, stated, "We are
honored to have someone with Secretary Thompson's background and
understanding of the healthcare industry join our Board of Directors. We
look forward to the guidance that will be brought to our Company through
Secretary Thompson's knowledge and experience."
As the former Secretary of the U.S. Department of Health & Human
Services Secretary ("HHS") from February 2001 to January 2005, Secretary
Thompson served as the nation's leading advocate for the health and
welfare of all Americans. He worked to modernize and add prescription
drug coverage to Medicare for the first time in the program's history. A
leading advocate of welfare reform, Secretary Thompson focused on
expanding services to seniors, people with disabilities, and low-income
Americans. Additionally, he is recognized for his contributions to the
U.S. response to the threat of bioterrorism and for his leadership in
the fight against HIV/AIDS in the United States and abroad.
Secretary Thompson is the former Independent Chairman of the Deloitte
Center for Health Solutions and is a former partner of the international
law firm of Akin Gump Strauss Hauer & Feld LLP ("Akin Gump"). At the
Deloitte Center for Health Solutions and at Akin Gump, Secretary
Thompson built on his efforts at HHS to develop solutions to the health
care challenges facing American families, businesses, communities,
states and the nation as a whole. These efforts focus on improving the
use of information technology in hospitals and doctors' offices,
promoting healthier lifestyles, strengthening and modernizing Medicare
and Medicaid, and expanding the use of medical diplomacy around the
TherapeuticsMD is a specialty pharmaceutical company focused on creating
safe and effective therapies exclusively for women. The Company's
branded OTC and pharmaceutical products are designed to improve the
health and well-being of women from pregnancy through menopause.
vitaMedMD provides dietary supplements and healthcare products focused
on improving women's health, wellness, and quality of life. Questions
may be directed to Daniel A. Cartwright, the Company's Chief Financial
Officer, at (561) 961-1911. More information on TherapeuticsMD is
available on its website at www.therapeuticsmd.com.
More information on vitaMedMD and its products are available at www.vitamedmdrx.com
This press release shall not constitute an offer to sell or a
solicitation of an offer to buy securities of TherapeuticsMD, Inc.
Certain statements in this release and other written or oral statements
made by or on behalf of the Company are "forward looking statements"
within the meaning of the federal securities laws. Statements regarding
future events and developments and our future performance, as well as
management's expectations, beliefs, plans, estimates or projections
relating to the future are forward-looking statements within the meaning
of these laws. The forward-looking statements are subject to a number of
risks and uncertainties including market acceptance of the Company's
services and projects and the Company's continued access to capital and
other risks and uncertainties. The actual results the Company achieves
may differ materially from any forward-looking statements due to such
risks and uncertainties. These statements are based on our current
expectations and speak only as of the date of such statements. The
Company undertakes no obligation to publicly update or revise any
forward-looking statement, whether as a result of future events, new
information or otherwise.